In December 2022, thought leaders from BioNTech, Bayer, Iperion and Beczek Consulting joined Generis for a live video discussion about the critical next steps as the Life Sciences industry embraces a future that is data rather than document driven in its management of information, knowledge and essential business processes. The panel considered how organisations in strictly regulated industries including the pharma, biotech and medical devices sectors might ensure that the data involved is sufficiently robust and reliable to enable confident re-use across multiple applications. Generis COO Max Kelleher chaired the proceedings, which included live audience interaction and asked who, ultimately, is going to look after the quality and consistency of the data – and how?
On the panel were:
- Dr. Melanie Ruppel, Senior Director Global Regulatory Affairs Regulatory Operations, BioNTech
- Vada A. Perkins, Executive Director, Regulatory Policy & Intelligence and Head of Regulatory Intelligence, Bayer Pharmaceuticals
- Frits Stulp, Managing Director, Iperion – a Deloitte company
- Preeya Beczek, Director & Independent Regulatory Affairs Expert, Beczek.Com
Download our white paper “The Big Debate – The future will be data driven”.